The effects of omega-3 in children with asthma
Not Applicable
- Conditions
- Asthma.Predominantly allergic asthma
- Registration Number
- IRCT2014111419940N1
- Lead Sponsor
- Vice-Chancellery of Research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
children with asthma diagnosed by sub specialist of asthma and allergy
Exclusion criteria: history of allergy to seafood; those under treatment with anti- leukotrienes and aspirin; side effects such as nausea and vomiting
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Respiratory symptoms including cough and wheeze. Timepoint: pre intervention and 3 months after intervention. Method of measurement: Questionnarie based on cough and wheeze in day and night.
- Secondary Outcome Measures
Name Time Method Pulmonary function. Timepoint: before intervention and after 3 months intervention. Method of measurement: spirometry.;Inflammatory and anti inflammatory cytokines. Timepoint: pre intervention and 3 months after intervention. Method of measurement: using flowcytometry.